Order Article Reprints

Stamatopoulos K, O’Farrell C, Simmons MJH, Batchelor HK, Mistry N. Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline. Pharmaceutics. 2023; 15(3):882. https://doi.org/10.3390/pharmaceutics15030882

Stamatopoulos, Konstantinos, Connor O’Farrell, Mark J. H. Simmons, Hannah K. Batchelor, and Nena Mistry. 2023. "Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline" Pharmaceutics 15, no. 3: 882. https://doi.org/10.3390/pharmaceutics15030882

Stamatopoulos, K., O’Farrell, C., Simmons, M. J. H., Batchelor, H. K., & Mistry, N. (2023). Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline. Pharmaceutics, 15(3), 882. https://doi.org/10.3390/pharmaceutics15030882